Vulnerability to tardive dyskinesia development in schizophrenia: An FDG-PET study of cerebral metabolism

被引:16
|
作者
Szymanski, S [1 ]
Gur, RC [1 ]
Gallacher, F [1 ]
Mozley, LH [1 ]
Gur, RE [1 ]
机构
[1] UNIV PENN,SCH MED,DEPT PSYCHIAT,MENTAL HLTH CLIN RES CTR,NEUROPSYCHIAT SECT,PHILADELPHIA,PA 19104
关键词
tardive dyskinesia; neuroimaging; schizophrenia;
D O I
10.1016/S0893-133X(96)00101-7
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
An understanding of the development of tardive dyskinesia (TD) may require prospective studies assessing the relationship of brain function measures to behavior. This study was undertaken to determine whether predisposition to the development of TD is related to abnormalities of cerebral F-18-labeled 2-fluoro-2-deoxy-D-glucose (FDG) position emission tomography (PET) measures in schizophrenia. A group of 42 patients without TD underwent FDG PET scanning for measuring cerebral metabolism as well as neuropsychological evaluation and magnetic resonance imaging. Patients were assessed longitudinally for TD development. Eight patients developed TD within 3 years. They were matched to eight patients without TD. Glucose metabolic rates and region/whole brain unties were examined in 38 regions of interest per hemisphere. Whole brain metabolism did Mot differ between the two groups. However, relative hypermetabolism in temporolimbic, brainstem, and cerebellar regions and hypoactivity in parietal and cingulate gyrus were found in the patients who later developed TD in contrast to those who did not. The groups were matched on clinical measures and had similar neuropsychological and neuroanatomic testing results. Thus, differences in the metabolic activity of specific brain regions are associated with vulnerability to TD development. (C) 1996 American College of Neuropsychopharmacology
引用
收藏
页码:567 / 575
页数:9
相关论文
共 50 条
  • [21] A Candidate Gene Study of Tardive Dyskinesia in the CATIE Schizophrenia Trial
    Tsai, Huei-Ting
    Caroff, Stanley N.
    Miller, Del D.
    McEvoy, Joseph
    Lieberman, Jeffrey A.
    North, Kari E.
    Stroup, T. Scott
    Sullivan, Patrick F.
    AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2010, 153B (01) : 336 - 340
  • [22] Association study of the estrogen receptor polymorphisms with tardive dyskinesia in schizophrenia
    Lai, IC
    Liao, DL
    Bai, YM
    Lin, CC
    Yu, SC
    Chen, JY
    Wang, YC
    NEUROPSYCHOBIOLOGY, 2002, 46 (04) : 173 - 175
  • [23] FDG-PET study in pathological gamblers
    Hollander, Eric
    Buchsbaum, Monte S.
    Haznedar, M. Mehmet
    Berenguer, Jessica
    Berlin, Heather A.
    Chaplin, William
    Goodman, Chelain R.
    LiCalzi, Elizabeth M.
    Newmark, Randall
    Pallanti, Stefano
    NEUROPSYCHOBIOLOGY, 2008, 58 (01) : 37 - 47
  • [24] Up- and down-modulations of cerebral glucose metabolism during acute Vestibular Neuritis: a FDG-PET study
    Buchmann, I
    Bense, S
    Lochmann, M
    Dieterich, M
    Schreckenberger, M
    Bartenstein, P
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S279 - S279
  • [25] Supraphysiological doses of L-Thyroxine alter regional cerebral metabolism in refractory bipolar depression: A FDG-PET study
    Bauer, M
    London, ED
    Rasgon, N
    Berman, SM
    Frye, MA
    Mozziotta, JC
    Altshuler, L
    Whybrow, PC
    PHARMACOPSYCHIATRY, 2003, 36 (05) : 212 - 213
  • [26] Thalamocortical effects of sertindole and haloperidol assessed by FDG-PET in schizophrenia
    Kemether, E.
    Buchsbaum, M.
    Byne, W.
    Haznedar, M.
    Hazlett, E.
    Chu, K. -W
    Goldstein, K.
    Goodman, C.
    Newmark, R.
    Tarosjan, Y.
    Gupta, A.
    Bark, N.
    Wolkin, A.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S282 - S282
  • [27] FDG-PET and MRI imaging of the effects of sertindole in the striatum in schizophrenia
    Buchsbaum, M.
    Gupta, A.
    Haznedar, M.
    Hazlett, E.
    Chu, K. W.
    Goldstein, K.
    Goodman, C.
    Newmark, R.
    Torosjan, Y.
    Bark, N.
    Wolkin, A.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S160 - S160
  • [28] FDG-PET Scans in Patients with Good and Poor Prognosis Schizophrenia
    Buchsbaum, Monte S.
    Bralet, Marie-Cecile
    Mitelman, Serge
    NEUROPSYCHOPHARMACOLOGY, 2013, 38 : S159 - S159
  • [29] FDG-PET and MRI imaging of the effects of sertindole in the striatum in schizophrenia
    Buchsbaum, M. S.
    Gupta, A.
    Haznedar, M. M.
    Hazlett, E.
    Chu, K. W.
    Goldstein, K.
    Goodman, C.
    Newmark, R.
    Torosjan, Y.
    Bark, N.
    Wolkin, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 : S414 - S414
  • [30] INCREASED VULNERABILITY TO TARDIVE-DYSKINESIA - DEVELOPMENT IN SCHIZOPHRENICS WITH CORTICAL METABOLIC DYSFUNCTION
    SZYMANSKI, S
    GUR, RC
    GALLACHER, F
    HARPERMOZLEY, L
    GUR, RE
    SCHIZOPHRENIA RESEARCH, 1995, 15 (1-2) : 101 - 101